Participants valued genetic testing for atrial fibrillation to better understand personal and familial risk and hoped it would improve clinical management, despite low current yield (~10-20%) of positive genetic results.
What is the perceived value of genetic testing for atrial fibrillation among patients and their families?
This study aims to investigate consumer interest and the perceived value of genetic testing for atrial fibrillation.
There is accumulating evidence that genetic variation can cause or affect susceptibility to atrial fibrillation (AF) 1. Although this argues for incorporation of genetic testing into clinical management, there is a lack of understanding of consumer interest in being tested and the value placed on genomic information about AF. Accordingly, this study aimed to investigate the perceived value of genetic testing for AF.
Fehlberg et al. (Sun,) conducted a other in Australian adults aged 18 years or older with lived experience of atrial fibrillation or family members with atrial fibrillation (n=14). Genetic testing for high-risk atrial fibrillation-related genes was evaluated on Perceived value of genetic testing for atrial fibrillation assessed by qualitative focus group discussions. Participants valued genetic testing for atrial fibrillation to better understand personal and familial risk and hoped it would improve clinical management, despite low current yield (~10-20%) of positive genetic results.